-
3 weeks ago | 
healio.com | Carol L. DiBerardino
Key takeaways: FDA warned of potential serious risks when using compounded topical finasteride. There are no FDA-approved topical formulations of the drug. The FDA issued an alert warning of potential serious risks associated with the use of compounded topical finasteride, which is marketed to treat hair loss but does not have agency-approved labeling.
-
3 weeks ago | 
dental.einnews.com | Sara Kellner |Carol L. DiBerardino
Offering HPV vaccines at dental visits improved uptake among children Added to email alerts You've successfully added Pediatric Vaccine-Preventable Diseases to your alerts. You will receive an email when new content is published. You've successfully added Pediatric Vaccine-Preventable Diseases to your alerts. You will receive an email when new content is published. We were unable to process your request. Please try again later.
-
4 weeks ago | 
healio.com | Raj Chovatiya |Erin Michael |Carol L. DiBerardino
In this video, Raj Chovatiya, MD, PhD, discusses updates on oral therapies in psoriasis from the American Academy of Dermatology Annual Meeting. “We saw updates largely in the oral therapeutic realm, even more so than the biologic therapeutic realm,” Chovatiya, who is a clinical associate professor for Chicago Medical School at Rosalind Franklin University and assistant clinical professor at George Washington University School of Health Sciences, said.
-
4 weeks ago | 
healio.com | Regina Schaffer |Kameelah Phillips |Carol L. DiBerardino
Key takeaways:About one in nine people who present with vaginitis symptoms also have at least one STI. CDC recommends co-testing for STIs when women are diagnosed with vaginitis, particularly bacterial vaginosis. Vaginitis, including yeast infections and bacterial vaginosis, affects up to 75% of women at least once in their lives, yet many women are unaware that a sexually transmitted infection, or STI, could be the cause.
-
4 weeks ago | 
healio.com | Gabrielle Capaldo |Carol L. DiBerardino |Heather Rogers |Susan Taylor
Key takeaways: The U.S. has not seen the approval of a new sunscreen ingredient since the 1990s. The FDA’s plan to phase out animal testing removes one of the obstacles standing between Americans and new sunscreens. The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of certain drugs, which could have implications for the approval of new sunscreen ingredients in the United States.
-
4 weeks ago | 
healio.com | Sara Kellner |Carol L. DiBerardino
Key takeaways: IL-6 levels peak 6 hours after infection, compared with 24 hours for traditional biomarkers. The biomarker was an effective early indicator of sepsis in children and pregnant women. VIENNA —Interleukin-6 could help physicians diagnose sepsis early in children and pregnant women, according to a real-world study presented at the ESCMID Global meeting 2025.
-
1 month ago | 
healio.com | Gabrielle Capaldo |Carol L. DiBerardino
Key takeaways: Overall, 84.1% and 70.5% of patients treated with icotrokinra achieved IGA 0 or 1 and PASI 90, respectively, by week 16. No new safety signals were identified. New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press release.
-
1 month ago | 
healio.com | Sara Kellner |Carol L. DiBerardino
Key takeaways: More than 3 million children died from AMR-associated complications in 2022. The use of watch and reserve antibiotics rose significantly from 2019 to 2021. VIENNA — More than 3 million children died from antimicrobial resistance-associated complications in 2022 across the globe, most of whom lived in Southeast Asia and Africa, according to findings presented at ESCMID Global 2025.
-
1 month ago | 
healio.com | Carol L. DiBerardino
Key takeaways: Tremfya is an interleukin-23 inhibitor being evaluated for the treatment of psoriatic arthritis. Twenty-four-week results showed Tremfya reduced signs, symptoms and structural progression of the disease. Editor’s note: This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic arthritis, as well as progression of structural damage, according to new phase 3 results.
-
1 month ago | 
healio.com | Sara Kellner |Carol L. DiBerardino
Key takeaways:Children with sleep-disordered breathing had lower health care use after tonsil removal. Those who had surgery had fewer skin- or pain-related conditions, likely because of decreased inflammation. Surgical removal of the adenoids and tonsils reduced the number of health care visits and prescriptions for children with mild sleep-disordered breathing compared with watchful waiting, a study found.
